1. Home
  2. AADI vs UAMY Comparison

AADI vs UAMY Comparison

Compare AADI & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AADI
  • UAMY
  • Stock Information
  • Founded
  • AADI 2011
  • UAMY 1968
  • Country
  • AADI United States
  • UAMY United States
  • Employees
  • AADI N/A
  • UAMY N/A
  • Industry
  • AADI Biotechnology: Pharmaceutical Preparations
  • UAMY Metal Fabrications
  • Sector
  • AADI Health Care
  • UAMY Industrials
  • Exchange
  • AADI Nasdaq
  • UAMY Nasdaq
  • Market Cap
  • AADI 33.6M
  • UAMY 36.9M
  • IPO Year
  • AADI N/A
  • UAMY N/A
  • Fundamental
  • Price
  • AADI $1.57
  • UAMY $0.36
  • Analyst Decision
  • AADI Buy
  • UAMY
  • Analyst Count
  • AADI 2
  • UAMY 0
  • Target Price
  • AADI $5.00
  • UAMY N/A
  • AVG Volume (30 Days)
  • AADI 291.8K
  • UAMY 224.0K
  • Earning Date
  • AADI 08-07-2024
  • UAMY 05-14-2024
  • Dividend Yield
  • AADI N/A
  • UAMY N/A
  • EPS Growth
  • AADI N/A
  • UAMY N/A
  • EPS
  • AADI N/A
  • UAMY N/A
  • Revenue
  • AADI $23,840,000.00
  • UAMY $9,313,701.00
  • Revenue This Year
  • AADI $4.21
  • UAMY N/A
  • Revenue Next Year
  • AADI $8.61
  • UAMY N/A
  • P/E Ratio
  • AADI N/A
  • UAMY N/A
  • Revenue Growth
  • AADI 26.97
  • UAMY N/A
  • 52 Week Low
  • AADI $1.28
  • UAMY $0.17
  • 52 Week High
  • AADI $7.24
  • UAMY $0.48
  • Technical
  • Relative Strength Index (RSI)
  • AADI 50.71
  • UAMY 60.04
  • Support Level
  • AADI $1.46
  • UAMY $0.27
  • Resistance Level
  • AADI $1.69
  • UAMY $0.40
  • Average True Range (ATR)
  • AADI 0.10
  • UAMY 0.02
  • MACD
  • AADI 0.02
  • UAMY 0.00
  • Stochastic Oscillator
  • AADI 67.75
  • UAMY 90.40

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

About UAMY United States Antimony Corporation

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.

Share on Social Networks: